Monthly Multi-Institutional Hematopathology Interesting Case Conference
Please join us for our next Monthly Multi-Institutonal Hematopathology Interesting Case Conference (MHICC). A collaborative meeting that brings together pathologists, clinicians and researchers from renowned institutions to discuss challenging and educational hematopathology cases. Learn More.
Session Four
Date: Wednesday, May 28, 2025
Time: 5:00PM (EST)
Presenting Institution: Cleveland Clinic
Zoom Meeting Link: Join Here
Meeting ID: 926 9111 9075
Passcode: 1234
Case 1: A 74-year-old male with history of squamous cell carcinoma of the tongue now presents with new tonsillar mass.
Case 2: A 65-year-old female with history of Inflammatory bowel disease on treatment presents with incidental finding of left adrenal cyst (16 cm) noted on imaging.
Case 3: An 82-year-old male with history of B-cell lymphoma from an outside hospital, now presenting with visible right neck lymphadenopathy and weight loss. Abbreviated ancillary studies provided for discussion around molecular findings.
Case 4: A 45-year-old male with an isolated enlarged left groin lymph node. View Slides
This interactive and case-based discussion forum offers a unique opportunity to engage with experts, review complex cases, and strengthen interdisciplinary collaboration in hematopathology.
For more information, please contact Reza Nejati, MD, Chair of the Organizing Committee, at [email protected].
Click here for more information and the 2025 case conference schedule.
Previous Cases
Date: Wednesday, April 23, 2025
Time: 5:00PM (EST)
Presenting Institution: MSKCC
Case 1: A 66F w/ history of breast carcinoma status post adjuvant chemotherapy and radiotherapy, presenting with neutropenia (ANC 0.7 K/uL), mild anemia (Hb 10.9 g/dL, MCV 95 fL, RDW 14%), and mild thrombocytopenia (Platelets 126 K/uL). View Slides
Case 2: A 58F w/ a history of a myeloid neoplasm favored to be oligomonocytic chronic myelomonocytic leukemia presents with widespread lymphadenopathy. View Slides
Case 3: A 63F with a history of breast carcinoma status post cytotoxic therapy presents with widespread lytic bone lesions, marked anemia (Hb 6.9 g/dL, MCV 98fL, RDW 22.1%) and thrombocytopenia (Platelets 64 K/uL). View Slides
This interactive and case-based discussion forum offers a unique opportunity to engage with experts, review complex cases, and strengthen interdisciplinary collaboration in hematopathology.
For more information, please contact Reza Nejati, MD, Chair of the Organizing Committee, at [email protected].
Click here for more information and the 2025 case conference schedule.
Date: February 26, 2025
Time: 5:00PM (EST)
Presenting Institution: FCCC
Case 1: A 70-year-old man with a history of chronic lymphocytic leukemia (CLL) with unexplained neutrophilia. View Slides
Case 2: A 68-year-old man with violaceous-pink raised skin lesions. View Slides
Case 3: A 65-year-old man with a history of multiple myeloma with worsening leukocytosis. View Slides
Case 4: A 56-year-old woman with a history of AML with inversion 16 now with pancytopenia including severe neutropenia at ~220 days post-transplant. View Slides
For more information, please contact Reza Nejati, MD, Chair of the Organizing Committee, at [email protected].
Date: Wednesday, March 19, 2025
Time: 5:00PM (EST)
Presenting Institution: Mount Sinai
Case 1: A 70-year-old man with a history of chronic lymphocytic leukemia (CLL) with
unexplained neutrophilia. View Slides
Case 2: A 68-year-old man with violaceous-pink raised skin lesions. View Slides
Case 3: A 65-year-old man with a history of multiple myeloma with worsening leukocytosis. View Slides
Case 4: A 56-year-old woman with a history of AML with inversion 16 now with pancytopenia including severe neutropenia at ~220 days post-transplant. View Slides
This interactive and case-based discussion forum offers a unique opportunity to engage with experts, review complex cases, and strengthen interdisciplinary collaboration in hematopathology.
For more information, please contact Reza Nejati, MD, Chair of the Organizing Committee, at [email protected].